These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21298648)

  • 1. Ion channel therapy of ischemic heart disease: from calcium channel blockers to late sodium current inhibition.
    Conti CR
    Clin Cardiol; 2011 Feb; 34(2):66-7. PubMed ID: 21298648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ion channel therapy of ischemic heart disease].
    Conti CR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Mar; 40(3):254-5. PubMed ID: 22801274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal protective action of T-, L-, and N-type Ca channel blockers].
    Hayashi K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():654-61. PubMed ID: 15171451
    [No Abstract]   [Full Text] [Related]  

  • 4. T-channel-selective calcium channel blockade: a promising therapeutic possibility, only preliminarily tested so far: a review of published data. T-Channel Calcium Channel Blocker Study Group.
    Van der Vring JA; Cleophas TJ; Van der Wall EE; Niemeyer MG
    Am J Ther; 1999 Jul; 6(4):229-33. PubMed ID: 11329102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective L-type, T-type, and nonspecific calcium-channel blockers for stable angina pectoris.
    Thadani U
    Am Heart J; 2002 Jul; 144(1):8-10. PubMed ID: 12094182
    [No Abstract]   [Full Text] [Related]  

  • 6. The structure and ion channel activity of 6-benzylamino-3-hydroxyhexa-cyclo[6.5.0.0(3,7).0(4,12).0(5,10).0(9,13]tridecane.
    Malan SF; Dyason K; Wagenaar B; Van Der Walt JJ; Van Der Schyf CJ
    Arch Pharm (Weinheim); 2003 Apr; 336(2):127-33. PubMed ID: 12761766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium antagonists: current and future applications based on new evidence. Cardio-protective effect of calcium antagonists].
    Hongo K; Yoshimura M
    Clin Calcium; 2010 Jan; 20(1):89-93. PubMed ID: 20048439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scaffold-based design and synthesis of potent N-type calcium channel blockers.
    Zamponi GW; Feng ZP; Zhang L; Pajouhesh H; Ding Y; Belardetti F; Pajouhesh H; Dolphin D; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6467-72. PubMed ID: 19815411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Late sodium current and calcium overload--pathogenesis and adequate treatment].
    Jacobshagen C
    Dtsch Med Wochenschr; 2013 Apr; 138(16):842-7. PubMed ID: 23589047
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium channel blockers: current controversies and basic mechanisms of action.
    Clusin WT; Anderson ME
    Adv Pharmacol; 1999; 46():253-96. PubMed ID: 10332505
    [No Abstract]   [Full Text] [Related]  

  • 12. Bradykinin induced a positive chronotropic effect via stimulation of T- and L-type calcium currents in heart cells.
    El-Bizri N; Bkaily G; Wang S; Jacques D; Regoli D; D'Orléans-Juste P; Sukarieh R
    Can J Physiol Pharmacol; 2003 Mar; 81(3):247-58. PubMed ID: 12733823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renoprotective effects of the L-/T-type calcium channel blocker benidipine in patients with hypertension.
    Tomino Y
    Curr Hypertens Rev; 2013 May; 9(2):108-14. PubMed ID: 23971692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of T-type versus L-type calcium-channel blockade on exercise duration in stable angina: results of the Posicor Reduction of Ischemia During Exercise (PRIDE) trial.
    Lee DS; Goodman S; Dean DM; Lenis J; Ma P; Gervais PB; Langer A;
    Am Heart J; 2002 Jul; 144(1):60-7. PubMed ID: 12094189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epinephrine reversed high-concentration bupivacaine-induced inhibition of calcium channels and transient outward potassium current channels, but not on sodium channel in ventricular myocytes of rats.
    Liu F; Wu B; Du Y; Wu Y; Chen H; Xia F; Jin Z; Xu X
    BMC Anesthesiol; 2015 Apr; 15():66. PubMed ID: 25924894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State-dependent verapamil block of the cloned human Ca(v)3.1 T-type Ca(2+) channel.
    Freeze BS; McNulty MM; Hanck DA
    Mol Pharmacol; 2006 Aug; 70(2):718-26. PubMed ID: 16699084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcium antagonists and ischemic heart disease].
    Simon K; Vályi P; Szépvölgyi A; Badics A; Böhm T
    Orv Hetil; 1996 Sep; 137(39):2131-6. PubMed ID: 8927361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping ventricular fibrillation: a simplified experimental model leads to a complicated result.
    Dosdall DJ
    Heart Rhythm; 2009 May; 6(5):693-5. PubMed ID: 19332392
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels.
    Hansen PB
    Acta Physiol (Oxf); 2013 Apr; 207(4):690-9. PubMed ID: 23351056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.